CAROTENÓIDES NO CÂNCER

HORMONE REPLACEMENT THERAPY AND THE RISK OF BREAST CANCER: ASSESSMENT OF THERAPY ACCEPTANCE IN A COHORT OF PREVIOUSLY TREATED BREAST CANCER PATIENTS.. Agnaldo Anelli,

Breast cancer and hormone replacement therapy: colaborative reanalysis of data from 51 epidemiological studies of 52705 women without breast cancer and 108411 women with breast

first occurrence of breast cancer in cohort studies and in case-control studies with the appearance of the first breast cancer; (c) mean follow-up time – minimum of ten years

receptor status of the first breast cancer affects the risk of CBC. Several studies show that, among breast cancer patients there is no effect of ER-status of the first cancer on

Considering possible different effects may exist between specific subtypes of fat (such as saturated fat, monounsaturated fat, and polyunsaturated fat,) on gastric cancer,it is

In this prospective study we report on the associations of serum GGT levels with the risk of breast cancer in a pooled population-based cohort of a total of 107,058 women

Our meta-analysis included only prospective cohort studies that reported the effect of coffee consumption on the risk of gastric or cardia cancer.. The out- come measure was

Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. Biology of HER2 and its importance in